Please login to the form below

Not currently logged in

Auden Mckenzie

This page shows the latest Auden Mckenzie news and features for those working in and with pharma, biotech and healthcare.

Actavis claims top UK generics spot with Auden Mckenzie buy

Actavis claims top UK generics spot with Auden Mckenzie buy

Actavis claims top UK generics spot with Auden Mckenzie buy. Firm claims the deal will make it the UK’ s third-largest pharma manufacturer. ... The Irish firm claims that when the Allergan and Auden Mckenzie deals close it will become the third-largest

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch table for January 2015 Deal Watch table for January 2015

    Asset acquisition. 470. Auden Mckenzie/Actavis. Purchase includes generic portfolio of 175 products making Actavis no 1 generic supplier in the UK.

  • Pharma deals during January 2015 Pharma deals during January 2015

    In particular, it is good to also be able to report on a deal where one of the DW team has played a role; Roger Davies advised Auden McKenzie on the

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...